New Science and Medical Research Hub Opens in Atlanta
Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition
New Science and Medical Research Hub Opens in Atlanta
Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition
Neurotech Moonshot: Georgia Tech Researcher Shares Impact of BRAIN Initiative in Congressional Briefing
Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.
Georgia Tech Researchers Identify Novel Gene Networks Associated with Aggressive Type of Breast Cancer
The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.
NIH awards $2.9M to Annoviant to advance heart disease technology
Grant is third NIH award for health technology startup.
Georgia Tech Researchers Develop More Broadly Protective Coronavirus Vaccine
Researchers at the Georgia Institute of Technology and the University of Wisconsin-Madison have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses
NeuroChamp Wins 2024 ACC InVenture Prize
Three Georgia Tech students who created a pediatric medical device won $15,000 Wednesday night during the 2024 ACC InVenture Prize, an annual undergraduate entrepreneurship competition.
Two-Way Cell-based Treatment Repairs Muscle After Rotator Cuff Injury
New treatment helps muscle regenerate following shoulder surgery
Real-Time Heat Protection Device Being Tested in Florida
Wearable bio-measurement device could alert people who work outside to dangerous levels of rising body temperature and dehydration that could help avoid heat-related injury.
A Clearer Image of Glaucoma
Georgia Tech chemists are exploring the behavior of a complex protein associated with glaucoma — characterizing one of the largest amyloid-forming proteins to date.